Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein–Barr virus

The CpG island methylator phenotype (CIMP), which is characterized by simultaneous methylation of the CpG islands of multiple genes, has been recognized as one of the important mechanisms in gastrointestinal carcinogenesis.

[1]  S. Leung,et al.  Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. , 1999, Cancer research.

[2]  N. Altorki,et al.  Infrequent point mutations of ras oncogenes in gastric cancers. , 1990, Gastroenterology.

[3]  T. Crook,et al.  p53 is frequently mutated in Burkitt's lymphoma cell lines. , 1991, The EMBO journal.

[4]  Z. Halpern,et al.  Activation of c-K-ras mutations in human gastrointestinal tumors. , 2000, Gastroenterology.

[5]  Richard A. Szucs,et al.  TNM Classification of Malignant Tumors. 5th ed , 1998 .

[6]  K. Offit,et al.  Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers. , 1998, Cancer research.

[7]  B. Rollins,et al.  DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras , 2003, Oncogene.

[8]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.

[9]  P. Laird,et al.  COBRA: a sensitive and quantitative DNA methylation assay. , 1997, Nucleic acids research.

[10]  A. Yang,et al.  Absence of p53 gene mutations in primary nasopharyngeal carcinomas. , 1992, Cancer research.

[11]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[12]  K. Chayama,et al.  K‐ras mutation in helicobacter pylori‐associated chronic gastritis in patients with and without gastric cancer , 2002, International journal of cancer.

[13]  E. Tokunaga,et al.  Prognostic value of p53 protein expression for patients with gastric cancer – a multivariate analysis , 1999, British Journal of Cancer.

[14]  S. Baylin,et al.  Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. , 1999, Cancer research.

[15]  M. Toyota,et al.  Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors , 2002, Oncogene.

[16]  H. Yokozaki,et al.  LETTER TO THE EDITOR. THE SEQUENTIAL ACCUMULATION OF GENETIC ALTERATIONS CHARACTERISTIC OF THE COLORECTAL ADENOMA‐CARCINOMA SEQUENCE DOES NOT OCCUR BETWEEN GASTRIC ADENOMA AND ADENOCARCINOMA , 1996, The Journal of pathology.

[17]  G. Offerhaus,et al.  Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway. , 2002, The American journal of pathology.

[18]  G. Kang,et al.  Correlation of p16 Hypermethylation with p16 Protein Loss in Sporadic Gastric Carcinomas , 2000, Laboratory Investigation.

[19]  M. Toyota,et al.  Aberrant Methylation and Histone Deacetylation Associated with Silencing of SLC5A8 in Gastric Cancer , 2004, Tumor Biology.

[20]  S. Shin,et al.  CpG Island methylator phenotype in colorectal cancer: A current perspective , 2008 .

[21]  J. Issa,et al.  CpG island methylation in gastroenterologic neoplasia: a maturing field. , 2004, Gastroenterology.

[22]  H. Lee,et al.  Epstein-Barr Virus-Positive Gastric Carcinoma Has a Distinct Protein Expression Profile in Comparison with Epstein-Barr Virus-Negative Carcinoma , 2004, Clinical Cancer Research.

[23]  J. Minna,et al.  Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma. , 2001, Cancer research.

[24]  Rachel Jones,et al.  Behavioural genetics: Worms gang up on bacteria , 2002, Nature Reviews Genetics.

[25]  Eva K. Lee,et al.  Predicting aberrant CpG island methylation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Ajani,et al.  Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  Minoru Toyota,et al.  Aberrant Promoter Methylation of the Transcription Factor Genes PAX5 α and β in Human Cancers , 2003 .

[28]  H. Yokozaki,et al.  Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR‐beta in intestinal, diffuse–adherent, and diffuse–scattered type gastric carcinomas , 2002, The Journal of pathology.

[29]  M. Toyota,et al.  Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  大澤 俊也.  Reduced expression and promoter methylation of p16 gene in Epstein-Barr virus-associated gastric carcinoma , 2003 .

[31]  P. Coates,et al.  Sensitive detection of Helicobacter pylori by using polymerase chain reaction , 1992, Journal of clinical microbiology.

[32]  Kazuhiro Yoshida,et al.  DNA hypermethylation and histone hypoacetylation of the HLTF gene are associated with reduced expression in gastric carcinoma , 2003, Cancer science.

[33]  T. Tursz,et al.  Alterations of the p53 gene in nasopharyngeal carcinoma , 1992, Journal of virology.

[34]  R Mera,et al.  Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach. , 2000, Human pathology.

[35]  G. Friedman,et al.  Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.

[36]  R. Collins,et al.  Presence of Simian Virus 40 DNA Sequences in Human Lymphoid and Hematopoietic Malignancies and Their Relationship to Aberrant Promoter Methylation of Multiple Genes , 2004, Cancer Research.

[37]  L. Szekely,et al.  EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[38]  佐藤 亜由美.  Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer , 2004 .

[39]  M. Toyota,et al.  Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  M. Rhyu,et al.  Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. , 2002, The American journal of pathology.

[41]  W. Doerfler,et al.  Insertion of Foreign DNA into an Established Mammalian Genome Can Alter the Methylation of Cellular DNA Sequences , 1999, Journal of Virology.

[42]  T. Nakajima,et al.  Infrequent Overexpression of p53 Protein in Epstein‐Barr Virus‐associated Gastric Carcinomas , 1997, Japanese journal of cancer research : Gann.

[43]  M. Gulley,et al.  Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation , 2002, Journal of clinical pathology.

[44]  M. Toyota,et al.  Distinct methylation pattern and microsatellite instability in sporadic gastric cancer , 1999, International journal of cancer.

[45]  P. Hohenberger,et al.  Gastric cancer. , 2003, Lancet.

[46]  Hoguen Kim,et al.  Concerted promoter hypermethylation of hMLH1, p16INK4A, and E‐cadherin in gastric carcinomas with microsatellite instability , 2003, The Journal of pathology.

[47]  N. Ahuja,et al.  Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  S. Clark,et al.  High sensitivity mapping of methylated cytosines. , 1994, Nucleic acids research.

[49]  N. Raab-Traub,et al.  Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas , 1994, Journal of virology.

[50]  S. Baylin,et al.  Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. , 1999, Cancer research.

[51]  R. Lotan,et al.  Hypermethylation and Silencing of the Putative Tumor Suppressor Tazarotene-Induced Gene 1 in Human Cancers , 2004, Cancer Research.

[52]  Japanese Gastric Cancer Association.  Japanese Classification of Gastric Carcinoma – 2nd English Edition – , 1998, Gastric Cancer.

[53]  M. Fukayama,et al.  Reduced Expression and Promoter Methylation p16 Gene in Epstein‐Barr Virus‐associated Gastric Carcinoma , 2002, Japanese journal of cancer research : Gann.

[54]  M. Toyota,et al.  Inactivation of the 14-3-3 sigma gene is associated with 5' CpG island hypermethylation in human cancers. , 2000, Cancer research.

[55]  Biao He,et al.  SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer , 2003, Proceedings of the National Academy of Sciences of the United States of America.